Clinical Outcomes and Patient Satisfaction After Corneal Neurotization.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 22 08 2020
accepted: 10 03 2021
entrez: 11 10 2021
pubmed: 12 10 2021
medline: 11 1 2022
Statut: ppublish

Résumé

The aim of this study was to assess clinical outcomes of corneal neurotization (CN) and determine patient perception of postoperative results. This was a retrospective study involving 29 eyes in 28 patients who underwent CN. Chart review data included demographic and clinical history; ophthalmic examination including visual acuity, ocular surface quality, and corneal sensation; surgical technique; and postoperative course. Subjective self-reported patient outcomes of surgical success were also assessed. Only eyes with at least 6 months of follow-up were included in the statistical analysis. A total of 24 eyes and 23 patients were included in statistical analyses. The median postoperative follow-up time was 12.2 months (interquartile range 10.9-18.5 mo). Twenty-three eyes (92%) achieved improvement in ocular surface quality. Eleven of 13 (85%) demonstrated healing of persistent epithelial defects at their last follow-up. Patients gained a median of 2.3 cm in Cochet-Bonnet esthesiometry measurements of sensation. No significant difference was found between preoperative and postoperative visual acuity. All 17 patients who provided self-assessment of their surgical outcome indicated they would undergo CN again if given the choice. Most of the patients reported that the postoperative pain was tolerable, with a median pain score of 3.0 on a 10-point scale (interquartile range 0.0-4.0). Sixteen patients (94%) reported full or partial return of skin sensation along the donor nerve distribution. CN provides improvement in corneal health and sensibility, with high patient satisfaction and minimal postoperative pain and morbidity.

Identifiants

pubmed: 34633356
doi: 10.1097/ICO.0000000000002759
pii: 00003226-202111000-00003
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1377-1386

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

I. M. Leyngold is a consultant for AxoGen Inc. The remaining authors have no conflicts of interest to disclose.

Références

Magendie F. The influence of the fifth pair of nerves on nutrition and function of the eye [in French]. J Physiol Exp Pathol. 1824;4:176–182.
Bonini S, Lambiase A, Rama P, et al. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000;107:1347–1352. discussion 1351–1352.
Bonini S, Rama P, Olzi D, et al. Neurotrophic keratitis. Eye (Lond). 2003;17:989–995.
Ueno H, Ferrari G, Hattori T, et al. Dependence of corneal stem/progenitor cells on ocular surface innervation. Invest Ophthalmol Vis Sci. 2012;53:867–872.
Lambiase A, Sacchetti M, Mastropasqua A, et al. Corneal changes in neurosurgically induced neurotrophic keratitis. JAMA Ophthalmol. 2013;131:1547–1553.
Mackie IA. Neuroparalytic keratitis. In: Fraunfelder F, Roy FH, Meyer SM, eds. Current Ocular Therapy. Philadelphia, PA: WB Saunders; 1995.
Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115–1120.
Bonini S, Lambiase A, Rama P, et al. Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology. 2018;125:1332–1343.
Pflugfelder SC, Massaro-Giordano M, Perez VL, et al. Topical recombinant human nerve growth factor (Cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial. Ophthalmology. 2020;127:14–26.
Chen HJ, Pires RT, Tseng SC. Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol. 2000;84:826–833.
Naik MN, Gangopadhyay N, Fernandes M, et al. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Eye (Lond). 2008;22:1132–1136.
Terzis JK, Dryer MM, Bodner BI. Corneal neurotization: a novel solution to neurotrophic keratopathy. Plast Reconstr Surg. 2009;123:112–120.
Malhotra R, Elalfy MS, Kannan R, et al. Update on corneal neurotisation. Br J Ophthalmol. 2019;103:26–35.
Elbaz U, Bains R, Zuker RM, et al. Restoration of corneal sensation with regional nerve transfers and nerve grafts: a new approach to a difficult problem. JAMA Ophthalmol. 2014;132:1289–1295.
Benkhatar H, Levy O, Goemaere I, et al. Corneal neurotization with a great auricular nerve graft: effective reinnervation demonstrated by in vivo confocal microscopy. Cornea. 2018;37:647–650.
Bourcier T, Henrat C, Heitz A, et al. Lateral antebrachial cutaneous nerve as autologous graft for Mini-Invasive Corneal Neurotization (MICORNE). Cornea. 2019;38:1029–1032.
Leyngold I, Weller C, Leyngold M, et al. Endoscopic corneal neurotization: technique and initial experience. Ophthalmic Plast Reconstr Surg. 2018;34:82–85.
Gomar AAG, Navas A, Nava A, et al. Infraorbital nerve transposition: description of a novel corneal neurotization technique in a cadaveric model. Invest Ophthalmol Vis Sci. 2011;52:722.
Fung SSM, Catapano J, Elbaz U, et al. In vivo confocal microscopy reveals corneal reinnervation after treatment of neurotrophic keratopathy with corneal neurotization. Cornea. 2018;37:109–112.
Gennaro P, Gabriele G, Aboh IV, et al. The second division of trigeminal nerve for corneal neurotization: a novel one-stage technique in combination with facial reanimation. J Craniofac Surg. 2019;30:1252–1254.
Jowett N, Pineda Ii R. Corneal neurotisation by great auricular nerve transfer and scleral-corneal tunnel incisions for neurotrophic keratopathy. Br J Ophthalmol. 2019;103:1235–1238.
Wisely CE, Rafailov L, Cypen S, et al. Clinical and morphologic outcomes of minimally invasive direct corneal neurotization. Ophthalmic Plast Reconstr Surg. 2020;36:451–457.
Leyngold IM, Latting MW, Yen MT. American Academy of Ophthalmology. Minimally invasive corneal neurotization technique. Available at: https://www.aao.org/clinical-video/minimally-invasive-corneal-neurotization-technique . Accessed May 25, 2020.
Leyngold IM. Minimally invasive endoscopic corneal neurotization: technique. AAO 2018 video program. 2018. Available at: https://www.aao.org/annual-meeting-video/minimally-invasive-endoscopic-corneal-neurotizatio . Accessed May 25, 2020.
Lin CH, Lai LJ. Herpetic corneal keratopathy management using ipsilateral supratrochlear nerve transfer for corneal neurotization. Ann Plast Surg. 2019;83:553–557.
Fogagnolo P, Giannaccare G, Bolognesi F, et al. Direct versus indirect corneal neurotization for the treatment of neurotrophic keratopahty: a multicenter prospective comparative study. Am J Ophthalmol. 2020;220:203–214.
Sulaiman W, Gordon T. Neurobiology of peripheral nerve injury, regeneration, and functional recovery: from bench top research to bedside application. Ochsner J. 2013;13:100–108.
Lu LM, McGhee CNJ, Sims JL, et al. High rate of recurrence of herpes zoster-related ocular disease after phacoemulsification cataract surgery. J Cataract Refract Surg. 2019;45:810–815.
Rafailov L, Leyngold IM. Clinical algorithm and rationale. In: Leyngold IM, Kossler AL, Yen MT, eds. Techniques in Corneal Neurotization. St. Louis, MO: Quality Medical Publishing; 2020.
Domeshek LF, Hunter DA, Santosa K, et al. Anatomic characteristics of supraorbital and supratrochlear nerves relevant to their use in corneal neurotization. Eye (Lond). 2019;33:398–403.
Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30:287–290.
Jacinto F, Espana E, Padilla M, et al. Ipsilateral supraorbital nerve transfer in a case of recalcitrant neurotrophic keratopathy with an intact ipsilateral frontal nerve: a novel surgical technique. Am J Ophthalmol Case Rep. 2016;4:14–17.
Sweeney AR, Wang M, Weller CL, et al. Outcomes of corneal neurotisation using processed nerve allografts: a multicentre case series. Br J Ophthalmol. 2020 [epub ahead of print]. doi:10.1136/bjophthalmol-2020-317361.
Safa B, Jain S, Desai MJ, et al. Peripheral nerve repair throughout the body with processed nerve allografts: results from a large multicenter study. Microsurgery. 2020;40:527–537.
Catapano J, Fung SSM, Halliday W, et al. Treatment of neurotrophic keratopathy with minimally invasive corneal neurotisation: long-term clinical outcomes and evidence of corneal reinnervation. Br J Ophthalmol. 2019;103:1724–1731.
Zhang QB, Dong YJ, Li ZB, et al. Coronal incision for treating zygomatic complex fractures. J Craniomaxillofac Surg. 2006;34:182–185.
Kim JS, Rafailov L, Leyngold IM. Corneal neurotization for postherpetic neurotrophic keratopathy: initial experience and clinical outcomes. Ophthalmic Plast Reconstr Surg. 2021;37:42–50.
Jowett N, Pineda Ii R. Acellular nerve allografts in corneal neurotisation: an inappropriate choice. Br J Ophthalmol. 2020;104:149–150.
Leyngold IM, Yen MT, Tian J, et al. Minimally invasive corneal neurotization with acellular nerve allograft: surgical technique and clinical outcomes. Ophthalmic Plast Reconstr Surg. 2019;35:133–140.
Zuniga JR, Williams F, Petrisor D. A case-and-control, multisite, positive controlled, prospective study of the safety and effectiveness of immediate inferior alveolar nerve processed nerve allograft reconstruction with ablation of the mandible for benign pathology. J Oral Maxillofac Surg. 2017;75:2669–2681.
Brooks DN, Weber RV, Chao JD, et al. Processed nerve allografts for peripheral nerve reconstruction: a multicenter study of utilization and outcomes in sensory, mixed, and motor nerve reconstructions. Microsurgery. 2012;32:1–14.
Rinker B, Zoldos J, Weber RV, et al. Use of processed nerve allografts to repair nerve injuries greater than 25 mm in the hand. Ann Plast Surg. 2017;78(6S suppl 5):S292–S295.
Mauch JT, Bae A, Shubinets V, et al. A systematic review of sensory outcomes of digital nerve gap reconstruction with autograft, allograft, and conduit. Ann Plast Surg. 2019;82(4S suppl 3):S247–S255.
Park JK, Charlson ES, Leyngold I, et al. Corneal neurotization: a review of pathophysiology and outcomes. Ophthalmic Plast Reconstr Surg. 2020;36:431–437.

Auteurs

Leon Rafailov (L)

Division of Oculoplastic Surgery, Department of Ophthalmology, Duke University Medical Center, Durham, NC.

Jane S Kim (JS)

Department of Ophthalmology, Duke University Medical Center, Durham, NC.

Clayton Ellis Wisely (CE)

Department of Ophthalmology, Duke University Medical Center, Durham, NC.

Edgar M Espana (EM)

Cornea and External Disease, Department of Ophthalmology, University of South Florida Morsani College of Medicine, Tampa, FL; and.

Matias Soifer (M)

Foster Center for Ocular Immunology, Duke University Medical Center, Durham, NC.

Ilya M Leyngold (IM)

Division of Oculoplastic Surgery, Department of Ophthalmology, Duke University Medical Center, Durham, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH